+ Filter
Loading...
CD19 & CD47
Loading...Anti-CD19 & CD47 Products
- anti-CD19 immunotoxin HD37 (scFv)-PE (AGTO-L047E)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- Anti-Human CD19 Recombinant Antibody (TAB-108CL) (TAB-108CL)
-
- Derivation: Human
- Species Reactivity: Human
- Type: Antibody
- Application: FC, ADCC, FuncS
- Mouse Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1611CL-F(E)) (TAB-1611CL-F(E))
-
- Species Reactivity: Human
- Type: Mouse Fab
- Application: Depletion, FuncS
- Anti-Human CD19 Recombinant Antibody (TAB-431CQ)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: IgG1, κ
- Application: ELISA, IHC, FC, IP, IF, FuncS
- Human Anti-CD47 Recombinant Antibody (TAB-303LC) (TAB-303LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Mouse Anti-CD47 Recombinant Antibody (clone MIAP410) (NEUT-388CQ)
-
- Species Reactivity: Human, Mouse, Rat
- Type: Mouse IgG1
- Application: Block, IF
- Human Anti-CD19 Recombinant Antibody (HPAB-0268-CN) (HPAB-0268-CN)
-
- Species Reactivity: Human, Cynomolgus monkey
- Type: Human IgG1
- Application: ELISA, FC
- Mouse Anti-CD19 Recombinant Antibody (TAB-1611CL) (TAB-1611CL)
-
- Species Reactivity: Human
- Type: Mouse IgG2a, κ
- Application: Depletion, FuncS
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG2b
- Application: WB, FC, IHC, IP, FuncS
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: WB, FC, ICC, IF, FuncS
- Human Anti-CD47 Recombinant Antibody (TAB-278LC) (TAB-278LC)
-
- Species Reactivity: Human
- Type: Human IgG, κ
- Application: Block, FuncS
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: IgG1 - kappa
- Application: IF, IP, Neut, FuncS, ELISA, FC, WB
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG1, κ
- Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: scFv fragment
-
- Derivation: Human
- Species Reactivity: Human
- Type: ADCC enhanced antibody
- Human Anti-CD47 Recombinant Antibody (TAB-289LC) (TAB-289LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-290LC) (TAB-290LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-291LC) (TAB-291LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-292LC) (TAB-292LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-293LC) (TAB-293LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-294LC) (TAB-294LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-295LC) (TAB-295LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-296LC) (TAB-296LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-297LC) (TAB-297LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-298LC) (TAB-298LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-299LC) (TAB-299LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-300LC) (TAB-300LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-301LC) (TAB-301LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-302LC) (TAB-302LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1612CL-S(P)) (TAB-1612CL-S(P))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: Depletion, FuncS
- Mouse Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1613CL-S(P)) (TAB-1613CL-S(P))
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Mouse scFv
- Application: Depletion, FuncS
- Mouse Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1614CL-S(P)) (TAB-1614CL-S(P))
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Mouse scFv
- Application: FuncS
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1612CL-F(E)) (TAB-1612CL-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: Depletion, FuncS
- Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1613CL-F(E)) (TAB-1613CL-F(E))
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric (mouse/human) Fab
- Application: Depletion, FuncS
- Human Anti-CD47 Recombinant Antibody; scFv Fragment (TAB-281LC-S(P)) (TAB-281LC-S(P))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; Fab Fragment (TAB-278LC-F(E)) (TAB-278LC-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; Fab Fragment (TAB-279LC-F(E)) (TAB-279LC-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; Fab Fragment (TAB-280LC-F(E)) (TAB-280LC-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-279LC) (TAB-279LC)
-
- Species Reactivity: Human
- Type: Human IgG, κ
- Application: Block, FuncS
- Human Anti-CD47 Recombinant Antibody (TAB-280LC) (TAB-280LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-281LC) (TAB-281LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-282LC) (TAB-282LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-283LC) (TAB-283LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-284LC) (TAB-284LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-285LC) (TAB-285LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-286LC) (TAB-286LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-287LC) (TAB-287LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody (TAB-288LC) (TAB-288LC)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized antibody
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; Fab Fragment (TAB-281LC-F(E)) (TAB-281LC-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; Fab Fragment (TAB-282LC-F(E)) (TAB-282LC-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; Fab Fragment (TAB-283LC-F(E)) (TAB-283LC-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; Fab Fragment (TAB-284LC-F(E)) (TAB-284LC-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; Fab Fragment (TAB-285LC-F(E)) (TAB-285LC-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; Fab Fragment (TAB-286LC-F(E)) (TAB-286LC-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; Fab Fragment (TAB-287LC-F(E)) (TAB-287LC-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; Fab Fragment (TAB-288LC-F(E)) (TAB-288LC-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; Fab Fragment (TAB-289LC-F(E)) (TAB-289LC-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; Fab Fragment (TAB-290LC-F(E)) (TAB-290LC-F(E))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized Fab
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; scFv Fragment (TAB-278LC-S(P)) (TAB-278LC-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; scFv Fragment (TAB-279LC-S(P)) (TAB-279LC-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA
- Human Anti-CD47 Recombinant Antibody; scFv Fragment (TAB-280LC-S(P)) (TAB-280LC-S(P))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: ELISA
- Mouse Anti-CD47 Recombinant Antibody (clone CBL377) (NEUT-387CQ)
-
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: Block, FC, CyTOF
- Rat Anti-CD47 Recombinant Antibody (clone miap301) (NEUT-389CQ)
-
- Species Reactivity: Mouse
- Type: Rat IgG2a, κ
- Application: FC, FuncS, Neut, WB
- Human Anti-CD19 Recombinant Antibody (HPAB-0264-CN) (HPAB-0264-CN)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG1, κ
- Application: ELISA, FC
- Human Anti-CD19 Recombinant Antibody (HPAB-0265-CN) (HPAB-0265-CN)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized IgG1, κ
- Application: ELISA, FC
- Human Anti-CD19 Recombinant Antibody (HPAB-0266-CN) (HPAB-0266-CN)
-
- Derivation: Humanized
- Species Reactivity: Human, Cynomolgus monkey
- Type: Humanized IgG
- Application: ELISA, FC
- Human Anti-CD19 Recombinant Antibody (HPAB-0267-CN) (HPAB-0267-CN)
-
- Derivation: Humanized
- Species Reactivity: Human, Cynomolgus monkey
- Type: Humanized IgG
- Application: ELISA, FC
- Anti-CD19 immunotoxin HD37 (IgG)-RTA (AGTO-G076R)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Anti-CD19 immunotoxin HD37 (IgG)-Sap (AGTO-G076S)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Anti-CD19 immunotoxin HD37 (IgG)-PAP (AGTO-G076P)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- Anti-CD19 immunotoxin HD37 (IgG)-PE (AGTO-G076E)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- anti-CD19 immunotoxin HD37 (scFv)-Sap (AGTO-L047S)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- Anti-CD19 immunotoxin HD37 (IgG)-DT (AGTO-G076D)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
- anti-CD19 immunotoxin HD37 (scFv)-PAP (AGTO-L047P)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG1, κ
- Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
- anti-CD19 immunotoxin HD37 (scFv)-DT (AGTO-L047D)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- anti-CD19 immunotoxin HD37 (scFv)-RTA (AGTO-L047R)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
- Mouse Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1611CL-S(P)) (TAB-1611CL-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: Depletion, FuncS
-
- Targets: CD19 & CD47
- Type: Tandem Diabody
- Application: FuncS, Promising therapeutic agent
- Anti-CD19 (clone huB4)-SMCC-DM1 ADC (ADC-157LZY)
-
- Target: CD19
- Linker: SMCC (4-[N-maleimidomethyl] cyclohexane-1 carboxylhydrazide).
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD19 (clone MDX1435)-vc-duocarmycin ADC (ADC-163LZY)
-
- Target: CD19
- Linker: VC (valine-citrulline)
- Drug: duocarmycin
- Anti-CD19 (clone B496)-SPP-DM1 ADC (ADC-181LZY)
-
- Target: CD19
- Linker: SPP (N-succinimidyl-4-(2-pyridyldithio)pentanoate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD19 (clone B496)-MCC-DM1 ADC (ADC-182LZY)
-
- Target: CD19
- Linker: MCC (Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
- Anti-CD19 (clone B496)-mc-vc-PABC-MMAE ADC (ADC-183LZY)
-
- Target: CD19
- Linker: mc-VC-PABC (maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: MMAE (monomethyl auristatin E)
- Anti-CD19 (clone B496)-mc-MMAF ADC (ADC-184LZY)
-
- Target: CD19
- Linker: mc (maleimidocaproyl)
- Drug: MMAF (monomethyl auristatin F)
- Anti-CD19 (hBU12)-Mc-MMAF ADC (SGN-19A) (ADC-L034)
-
- Target: CD19
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
-
- Target: CD19
- Linker: mc-vc (maleimidocaproyl-valine-alanine)
- Drug: pyrrolobenzodiazepine (PBD) dimers SGD-1882
- Anti-CD19 (clone BU12)-MC-MMAF ADC (ADC-189CL)
-
- Target: CD19
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD19 (clone hBU12)-vcPAB-MMAE ADC (ADC-150CL)
-
- Target: CD19
- Linker: VC-PAB (valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD19 (hBU12)-mcMMAF ADC (ADC-017LCT)
-
- Target: CD19
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
- Anti-CD19 (hBU12)-Mc-MMAE ADC (ADC-019LCT)
-
- Target: CD19
- Linker: Mc (maleimidocaproyl)
- Drug: MMAE (Monomethyl auristatin E)
- Anti-CD19 (huB4)-SPDB-DM4 ADC (ADC-020LCT)
-
- Target: CD19
- Linker: SPDB (N-succinimidyl 4-(2-pyridyldithio)butyrate)
- Drug: DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine)
- Anti-CD19 (clone huB4)-mc-MMAF ADC (ADC-045LZY)
-
- Target: CD19
- Linker: mc (maleimidocaproyl)
- Drug: MMAF (monomethyl auristatin F)
- Anti-CD19 (Denintuzumab)-Mc-MMAF ADC (ADC-175LCT)
-
- Target: CD19
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
-
- Host Species: Human
- Specificity: Human
- Type: Chimeric antibody (mouse/human)
- Classification: Fc glycosylation/Low fucosylated
- Glycosylation site: Asn297 in Fc region
- Glycoform (ratio): GN-GN-M-(M-GN)2
-
- Host Species: Human
- Specificity: Human
- Type: Chimeric antibody (mouse/human)
- Classification: Fc glycosylation/Low fucosylated
- Glycosylation site: Asn297 in Fc region
- Glycoform (ratio): GN-GN-M-(M-GN)2
-
- Host Species: Mouse
- Specificity: Human
- Type: Mouse antibody
- Classification: Fc glycosylation
- Glycosylation site: Fc region
- Glycoform (ratio): G2-NANA
-
- Host Species: Human
- Specificity: Human
- Type: Humanized antibody
- Classification: Fc glycosylation/Non fucosylated
- Glycosylation site: Asn297 in Fc region
-
- Host Species: Human
- Specificity: Human
- Type: Humanized antibody
- Classification: Fc glycosylation/Non fucosylated
- Glycosylation site: Asn297 in Fc region
View More Products
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Background
This gene encodes a membrane protein, which is involved in the increase in intracellular calcium concentration that occurs upon cell adhesion to extracellular matrix. The encoded protein is also a receptor for the C-terminal cell binding domain of thrombospondin, and it may play a role in membrane transport and signal transduction. This gene has broad tissue distribution, and is reduced in expression on Rh erythrocytes.
Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. This gene encodes a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.


Primary Immunodeficiency
